Immunological consequences of asbestos exposure.
D000818:Animals; D000917:Antibody Formation / Q000187:drug effects*; D001194:Asbestos / Q000009:adverse effects / Q000494:pharmacology* / Q000633:toxicity; D001195:Asbestosis / Q000276:immunology / Q000473:pathology; D001323:Autoantibodies / Q000032:analysis; D001402:B-Lymphocytes / Q000276:immunology; D004391:Dust; D006801:Humans; D006968:Hypersensitivity, Delayed / Q000209:etiology / Q000276:immunology; D007111:Immunity, Cellular / Q000187:drug effects*; D008211:Lymphocyte Cooperation; D008222:Lymphokines / Q000502:physiology; D008264:Macrophages / Q000276:immunology; D051379:Mice; D010587:Phagocytosis; D011650:Pulmonary Alveoli / Q000187:drug effects / Q000473:pathology; D051381:Rats
D001323:Autoantibodies; D004391:Dust; D008222:Lymphokines; D001194:Asbestos